Cytomegaloviruses (CMVs) are controlled by innate and adaptive immune responses in an immunocompetent host while causing multiple organ diseases in an immunocompromised host. A risk group of high clinical relevance comprises transiently immunocompromised recipients of hematopoietic cell transplantation (HCT) in the “window of risk” between eradicative therapy of hematopoietic malignancies and complete reconstitution of the immune system. Cellular immunotherapy by adoptive transfer of CMV-specific CD8 T cells is an option to prevent CMV disease by controlling a primary or reactivated infection. While experimental models have revealed a viral epitope-specific antiviral function of cognate CD8 T cells, the site at which control is exerted rema...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Successful reconstitution of cytomegalovirus (CMV)-specific CD8+ T cells by hematopoietic cell trans...
Cytomegalovirus (CMV) is a β-herpesvirus that establishes a persistent latent infection in a large p...
Cytomegalovirus (CMV) infection in the period of temporary immunodeficiency after haematoablative tr...
Abstract Infections with cytomegalovirus (CMV) can cause severe disease in immunosuppressed patient...
Viruses in the Herpesviradae family cause latent infections that require life-long immune control fr...
Viruses in the Herpesviradae family cause latent infections that require life-long immune control fr...
Viruses in the Herpesviradae family cause latent infections that require life-long immune control fr...
In the immunocompetent host, primary cytomegalovirus (CMV) infection is resolved by the immune respo...
Severe disease associated with cytomegalovirus (CMV) infection is still a major problem in patients...
Reactivation of latent cytomegalovirus (CMV) endangers the therapeutic success of hematopoietic cell...
Cytomegalovirus (CMV) is a leading infectious cause of morbidity in immune-compromised patients. γδ ...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Successful reconstitution of cytomegalovirus (CMV)-specific CD8+ T cells by hematopoietic cell trans...
Cytomegalovirus (CMV) is a β-herpesvirus that establishes a persistent latent infection in a large p...
Cytomegalovirus (CMV) infection in the period of temporary immunodeficiency after haematoablative tr...
Abstract Infections with cytomegalovirus (CMV) can cause severe disease in immunosuppressed patient...
Viruses in the Herpesviradae family cause latent infections that require life-long immune control fr...
Viruses in the Herpesviradae family cause latent infections that require life-long immune control fr...
Viruses in the Herpesviradae family cause latent infections that require life-long immune control fr...
In the immunocompetent host, primary cytomegalovirus (CMV) infection is resolved by the immune respo...
Severe disease associated with cytomegalovirus (CMV) infection is still a major problem in patients...
Reactivation of latent cytomegalovirus (CMV) endangers the therapeutic success of hematopoietic cell...
Cytomegalovirus (CMV) is a leading infectious cause of morbidity in immune-compromised patients. γδ ...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...
Although the relative contribution of different immune effector functions to clearing tissues of cyt...